Europe Patient Monitoring Market is expected to reach USD 21.21 billion by 2030

The rising government initiatives create demand for the health monitoring devices is driving the growth of Europe Patient Monitoring market during the forecast period.

Europe Patient Monitoring Market was valued at USD 12.53 billion in 2023, and is predicted to reach USD 21.21 billion by 2030, with a CAGR of 7.5% from 2024 to 2030, according to new research by Next Move Strategy Consulting. Governments across Europe are driving the expansion of the patient monitoring market by implementing strategic initiatives. Acknowledging the significance of a robust healthcare system, governments are allocating resources to modernize healthcare infrastructure, including hospitals and clinics. This enables the seamless incorporation of cutting-edge technologies, such as patient monitoring systems. To promote the adoption of modern healthcare technologies, governments frequently provide incentives and establish supportive regulatory frameworks, encouraging collaboration between the public and private sectors.

Also, the increasing prevalence of chronic diseases, including cardiovascular diseases, diabetes, and respiratory illnesses, is driving the growth of the patient monitoring market in Europe. Patient monitoring devices are essential for managing chronic conditions by providing real-time data on vital signs and medication adherence, allowing for timely interventions and preventive measures. This growing burden of chronic diseases demands advanced healthcare solutions, leading to increased investment in patient monitoring technologies.

However, connectivity issues pose a major obstacle to the growth of the patient monitoring market. These issues disrupt real-time data transmission and communication between devices, jeopardizing the timeliness and accuracy of patient information. Overcoming these challenges is critical to unlocking the full potential of patient monitoring technology and enabling its widespread adoption across the healthcare sector.

On the contrary, Artificial Intelligence (AI) and Machine Learning (ML) are revolutionizing patient monitoring by unlocking the power of vast datasets. By analyzing historical patient data, AI algorithms can detect subtle patterns and anomalies in vital signs and medical history, enabling early detection of potential health concerns before symptoms arise, paving the way for timely interventions.

Furthermore, AI and ML foster personalized medicine, tailoring treatment plans to each patient's unique characteristics and responses. These technologies aid in risk stratification, assisting healthcare providers in prioritizing interventions for patients at a higher risk of developing specific medical conditions or complications.

Request for a sample here:

According to the report, leading players in the Europe patient monitoring market include Medtronic Plc, Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, Nihon Kohden Corporation, Abbott Laboratories, Masimo Corporation, Hill-Rom Holdings, Inc., Biotronik SE & Co. KG, Honeywell International, Inc., and others.

Key Insights from the Europe Patient Monitoring Market Report:

  • The information related to key drivers, restraints, and opportunities and their impact on the Europe patient monitoring market is provided in the report.

  • The value chain analysis in the market study provides a clear picture of the roles of each stakeholder.

  • The market share of players in the Europe patient monitoring market is provided in the report along with their competitive analysis.

Share this post?


No comment available , be the first one!

Leave a Reply